Literature DB >> 8839759

Immunolocalization of cell-wall-deficient forms of Mycobacterium tuberculosis complex in sarcoidosis and in sinus histiocytosis of lymph nodes draining carcinoma.

H A Alavi1, E A Moscovic.   

Abstract

In sarcoidosis, pleomorphic chromogens (PCs) occur as multivariate pigmented elements within sinusoids of lymph nodes (sinusoidal phase) and as tiny "round bodies" detectable in granulomas (generalized phase). The sinusoidal phase occurs in other conditions as well and characteristically contains yeastlike bodies also known as H-W bodies. To elucidate the antigenic profile of all variant forms, 28 cases of sarcoidosis (series A) and 14 cases of malignancy associated sinus histiocytosis (series B) were studied immunohistochemically with panels of various antibodies, including antimycobacterial MAbs specific for M tuberculosis complex (TB68, TB71), for M. leprae (MMP-I-3C3) and for cross-reactive mycobacterial antigens (F24-2-3 and F116-5, the latter recognizing superoxide dismutase). Results for series A indicate that: 1) PCs are cell-wall-deficient (CWD) mycobacterial forms belonging to M. tuberculosis complex (over 95%); 2) both phases are antigenically identical parts of the L-cycle; 3) "round bodies" of the "infective" phase have an endolysosomal evolution; 4)uncommon vacuolated forms represent a labile spheroplast stage; 5) the yeastlike bodies are specialized sinusoidal large bodies of unknown function. Results for series B show that in roughly two thirds of cases the pigmented forms are also CWD mycobacteria, have the same immunophenotype as sarcoid PCs in 35.7% of cases, have a much higher incidence of labile vacuolated forms and, finally, that malignancy associated "pseudosarcoid" granulomas do not differ antigenically from genuine sarcoid granulomas. Unlike conventional mycobacteria, PCs do not express cytoskeletal proteins consistently. Their general reactivity for HBcAg raises the possibility of phage interactions being responsible for the L-cycle since it may reflect shared epitopes between unrelated virus entities.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8839759

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  8 in total

Review 1.  Evidence for mycobacteria in sarcoidosis.

Authors:  Isaac Brownell; Francisco Ramírez-Valle; Miguel Sanchez; Stephen Prystowsky
Journal:  Am J Respir Cell Mol Biol       Date:  2011-06-09       Impact factor: 6.914

Review 2.  Mycobacteria and sarcoidosis.

Authors:  O M Kon; R M du Bois
Journal:  Thorax       Date:  1997-08       Impact factor: 9.139

Review 3.  Sarcoidosis vs. Sarcoid-like reactions: The Two Sides of the same Coin?

Authors:  Georgi Tchernev; Claudio Tana; Cosima Schiavone; José-Carlos Cardoso; Julian Ananiev; Uwe Wollina
Journal:  Wien Med Wochenschr       Date:  2014-03-25

4.  Localization of propionibacterium acnes in granulomas supports a possible etiologic link between sarcoidosis and the bacterium.

Authors:  Mariko Negi; Tamiko Takemura; Josune Guzman; Keisuke Uchida; Asuka Furukawa; Yoshimi Suzuki; Tadatsune Iida; Ikuo Ishige; Junko Minami; Tetsuo Yamada; Hiroshi Kawachi; Ulrich Costabel; Yoshinobu Eishi
Journal:  Mod Pathol       Date:  2012-05-18       Impact factor: 7.842

Review 5.  Etiology of sarcoidosis: does infection play a role?

Authors:  Shiv Saidha; Elias S Sotirchos; Christopher Eckstein
Journal:  Yale J Biol Med       Date:  2012-03-29

Review 6.  Sarcoidosis: Immunopathogenesis and Immunological Markers.

Authors:  Wei Sheng Joshua Loke; Cristan Herbert; Paul S Thomas
Journal:  Int J Chronic Dis       Date:  2013-07-25

7.  Depletion of M. tuberculosis GlmU from Infected Murine Lungs Effects the Clearance of the Pathogen.

Authors:  Vijay Soni; Sandeep Upadhayay; Priyanka Suryadevara; Ganesh Samla; Archana Singh; Perumal Yogeeswari; Dharmarajan Sriram; Vinay Kumar Nandicoori
Journal:  PLoS Pathog       Date:  2015-10-21       Impact factor: 6.823

Review 8.  The Role of Infection in Interstitial Lung Diseases: A Review.

Authors:  Natalya Azadeh; Andrew H Limper; Eva M Carmona; Jay H Ryu
Journal:  Chest       Date:  2017-04-08       Impact factor: 9.410

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.